SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gensyn, the Network for Machine Intelligence, is an open infrastructure layer for AI. It provides the foundational infrastructure AI needs to operate at scale, including compute, data, and information exchange, by enabling both humans and machines to participate in open digital markets. Built with native support for AI communication, identification, and verification, Gensyn serves as the economic backbone for continual learning over new decentralised AI models and applications, without centralised control.  Gensyn is backed by a16z crypto, CoinFund, Galaxy Digital, Eden Block, Maven 11, and more. For more information, visit http://gensyn.ai

Gensyn

Gensyn is attracting significant attention following its new listings on major exchanges like Coinbase and Binance, fueling community optimism around its role in the booming artificial intelligence crypto sector. Investors are actively discussing the token's growth potential alongside broader industry catalysts like the Clarity Act and the increasing institutional focus on AI-driven decentralized infrastructure.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing a significant surge in retail interest and bullish momentum, largely fueled by reports of major institutional accumulation, including disclosed purchases by Donald Trump, and continued alignment with key industry partners like Nvidia. Community discussions highlight a broader rotation of capital out of overheated semiconductor stocks and into established SaaS players, with traders debating whether this recovery signals a sustained comeback for high-quality software firms or a temporary relief rally.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is facing intense community scrutiny and negative sentiment as investors react to leadership decisions regarding Ethereum accumulation and share dilution. While some market participants remain focused on the company's long-term crypto treasury strategy, active discussions are dominated by frustration over recent price underperformance and skepticism toward leadership's public statements.

TOSHI

TOSHI is trending as investors debate the potential for a long-term turnaround, with many community members highlighting the asset's large holder base and speculation around future exchange listings. Bullish sentiment remains focused on the token's status as a major player on the Base network while retail traders discuss accumulation strategies despite recent market volatility.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as the company resumes oil transport through its Santa Ynez pipeline following a federal order under the Defense Production Act. The community is actively discussing the high short interest and the potential for a major short squeeze, as investors weigh the stock's significant production ramp-up against ongoing legal friction between the company and California regulators.

EchoStar Corp. engages in the design, development, and distribution of digital set-top boxes and products for direct-to-home satellite service providers. It operates through the following business segments: Pay-TV, Retail Wireless, and Broadband and Satellite Services. The Pay-TV segment business strategy is to be the best provider of video services in the United States by providing products with the best technology, outstanding customer service, and great value. The Retail Wireless segment offers Retail Wireless services as well as a competitive portfolio of wireless devices. The Broadband and Satellite Services segment business strategy is to maintain and improve leadership position and competitive advantage through development of technologies and services marketed to selected sectors within the consumer, enterprise and government markets globally. The company was founded by Charlie William Ergen, Candy Ergen, and James DeFranco in 1980 and is headquartered in Englewood, CO.

EchoStar Corp - Ordinary Shares - Class A

EchoStar Corp

EchoStar Corp is trending as investors aggressively position themselves for an anticipated SpaceX IPO, with the stock increasingly treated as a primary public proxy due to its significant equity stake in the company. Community discussion is dominated by analysis of EchoStar's spectrum deals, bullish call flow, and speculative short-squeeze narratives as traders debate the company's valuation relative to its SpaceX holdings.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund ($XLF) is currently seeing heightened volatility and mixed sentiment as investors weigh bank earnings and the potential impact of sector-wide regulatory shifts. Market participants are actively debating whether these technical pullbacks represent a structural breakdown or a buying opportunity amidst broader sector rotation and concerns over credit quality.

Tema ETF Trust - Tema Space Innovators ETF

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent Biosolutions is capturing investor interest as a potential play on heightened global biodefense demand, fueled by concerns over the re-emergence of serious infectious threats and broader geopolitical instability. The community is actively debating the company's turnaround progress under management, with a sharp focus on upcoming government procurement opportunities and the impact of debt restructuring efforts on the stock's long-term valuation.

Southwest Airlines Co. engages in the operation and management of a passenger airline. The firm also offers ancillary services such as early bird check-in, upgraded boarding, and transportation of pets and unaccompanied minors. It operates in the United States, the Commonwealth of Puerto Rico, Mexico, Jamaica, the Bahamas, Aruba, Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. The company was founded by Rollin W. King and Herbert D. Kelleher on March 9, 1967 and is headquartered in Dallas, TX.

Southwest Airlines Co

Southwest Airlines is trending due to the company's aggressive business model shift, including the introduction of assigned seating and new baggage fees designed to drive profitability. Investors are closely monitoring the impact of these changes on revenue growth and margin expansion, while community sentiment remains divided over the airline's move away from its traditional low-cost, open-seating heritage.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Black Diamond stock rises after its Q1 results reflect lower costs, a cash runway into 2028 and continued progress for lead candidate silevertinib.

Black Diamond Therapeutics (BDTX) to Release Quarterly Earnings on Monday

Black Diamond Therapeutics (NASDAQ:BDTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-black-diamond-therapeutics-inc-stock...

HC Wainwright Issues Positive Forecast for BDTX Earnings

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - HC Wainwright upped their Q1 2026 earnings estimates for shares of Black Diamond Therapeutics in a research note issued on Wednesday...

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

Investors need to pay close attention to BDTX stock based on the movements in the options market lately.

Jefferies Financial Group Upgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Strong-Buy

Jefferies Financial Group upgraded shares of Black Diamond Therapeutics to a "strong-buy" rating in a report on Thursday...

BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize

Black Diamond Therapeutics bets on brain-penetrant EGFR drug silevertinib, targeting C797S resistance and CNS metastases as key edge in crowded lung cancer market.

BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right

Black Diamond Therapeutics hinges on silevertinib, with 2026 data on progression-free survival and durability set to determine whether its single-asset story can justify upside.

Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks

BDTX rides on silevertinib, with 2026 durability data set to test early NSCLC efficacy and CNS signals, making upcoming readouts a decisive swing factor.

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

Black Diamond (BDTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Consensus Rating of "Moderate Buy" from Analysts

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the firm, MarketBeat reports...

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

BDTX
Black Diamond Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest BDTX News

BDTXBlack Diamond Therapeutics Inc